FRX: Forest Laboratories develops, manufactures, and sells branded forms of drug products.
Closing Price: 32.48
52-Week Price Range: 24.17-34.17
Risk: You need to further evaluate FRX thoroughly. Well-informed, you decide what to do. Remember that there is risk of loss in all trading. I don’t own any FRX shares. Here are the pluses and minuses.
+ Beta: 0.79
+ Debt: FRX has no long-term debt.
– Dividend: Currently, FRX does not pay a dividend.
+ Earnings: For the third quarter of 2011, analysts estimate FRX will earn $0.99 per share and that is a 16.92% increase over the 2010 third-quarter earnings per share of $0.69.
+ Free Cash Flow: 3.25
+ Morningstar Rating: 3-star
– PE: 15.10
– Price/Book Ratio: 1.93
– Price/Sales Ratio: 2.17
+ Sales: 4,275.9 million in trailing 12-month sales